C1orf50 and breast cancer: Upon analyzing data from The Cancer Genome Atlas-Breast Invasive Carcinoma (TCGA-BRCA) dataset, we discovered that C1orf50 is strongly correlated with the prognosis of stage II Luminal A breast cancer, which is considered to have low biological malignancy among ER-positive breast cancers.